(Q37631072)

21 August 2017

1 reference

title

Progestagen component in combined hormone replacement therapy in postmenopausal women and breast cancer risk: a debated clinical issue (English)

1 reference

Hormone Replacement Therapy

21 August 2017

main subject

1 reference

1

1 reference

21 August 2017

Nicoletta Biglia

2

1 reference

21 August 2017

Stefania Cosio

series ordinal

3

1 reference

21 August 2017

Piero Sismondi

series ordinal

4

1 reference

21 August 2017

Andrea Riccardo Genazzani

series ordinal

5

1 reference

21 August 2017

language of work or name

1 reference

1 December 2009

1 reference

Gynecological Endocrinology

21 August 2017

published in

1 reference

21 August 2017

volume

25

1 reference

21 August 2017

issue

12

1 reference

21 August 2017

page(s)

807-815

1 reference

Production and actions of estrogens

21 August 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F09513590903056878

The Effect of Progesterone and Synthetic Progestins on Serum- and Estradiol-Stimulated Proliferation of Human Breast Cancer Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590903056878

Breast cancer and sex steroids: critical review of epidemiological, experimental and clinical investigations on etiopathogenesis, chemoprevention and endocrine treatment of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590903056878

Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Collaborative Group on Hormonal Factors in Breast Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590903056878

Menopausal estrogen and estrogen-progestin replacement therapy and breast cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590903056878

Effect of hormone replacement therapy on breast cancer risk: estrogen versus estrogen plus progestin

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590903056878

Hormone replacement therapy regimens and breast cancer risk(1).

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590903056878

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590903056878

Relation of regimens of combined hormone replacement therapy to lobular, ductal, and other histologic types of breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590903056878

Hormone replacement therapy containing progestins and given continuously increases breast carcinoma risk in Sweden.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590903056878

Role of progestogen in hormone therapy for postmenopausal women: position statement of The North American Menopause Society

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590903056878

Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590903056878

Menopause: evidence-based practice

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590903056878

Current evidence about the effect of hormone replacement therapy on the incidence of major conditions in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590903056878

Postmenopausal hormone therapy and breast cancer: what is the problem?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590903056878

Hormone replacement therapy use and variations in the risk of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590903056878

Progestins and progesterone in hormone replacement therapy and the risk of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590903056878

Breast cancer risk in relation to different types of hormone replacement therapy in the E3N-EPIC cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590903056878

Could transdermal estradiol + progesterone be a safer postmenopausal HRT? A review.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590903056878

Unequal risks for breast cancer associated with different hormone replacement therapies: results from the E3N cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590903056878

Crosstalk between the insulin-like growth factors and estrogens in breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590903056878

Regulation of cell signalling cascades by steroid hormones

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590903056878

Estrogen signaling via a linear pathway involving insulin-like growth factor I receptor, matrix metalloproteinases, and epidermal growth factor receptor to activate mitogen-activated protein kinase in MCF-7 breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590903056878

Effect of estrogen on telomerase activity in human breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590903056878

Hormones and growth factors regulate telomerase activity in ageing and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590903056878

Melatonin down-regulates hTERT expression induced by either natural estrogens (17beta-estradiol) or metalloestrogens (cadmium) in MCF-7 human breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590903056878

Letrozole as a potent inhibitor of cell proliferation and expression of metalloproteinases (MMP-2 and MMP-9) by human epithelial breast cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590903056878

In vitro regulation of vascular endothelial growth factor by estrogens and antiestrogens in estrogen-receptor positive breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590903056878

Raloxifene inhibits estrogen-induced up-regulation of telomerase activity in a human breast cancer cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590903056878

Vascular endothelial growth factor reduces tamoxifen efficacy and promotes metastatic colonization and desmoplasia in breast tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590903056878

Extra-nuclear signalling of estrogen receptor to breast cancer cytoskeletal remodelling, migration and invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590903056878

Biphasic regulation of breast cancer cell growth by progesterone: role of the cyclin-dependent kinase inhibitors, p21 and p27(Kip1).

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590903056878

Convergence of progesterone and epidermal growth factor signaling in breast cancer. Potentiation of mitogen-activated protein kinase pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590903056878

Progestin effects on long-term growth, death, and Bcl-xL in breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590903056878

Transcriptional hyperactivity of human progesterone receptors is coupled to their ligand-dependent down-regulation by mitogen-activated protein kinase-dependent phosphorylation of serine 294.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590903056878

A rationale for inhibiting progesterone-related pathways to combat breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590903056878

Exogenous progestagens and the human breast

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590903056878

Intrinsic estrogenicity of some progestagenic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590903056878

Induction of estrogen receptor-alpha and -beta activities by synthetic progestins

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590903056878

Estrogen and progestin regulation of cell cycle progression

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590903056878

Antiprogestin inhibition of cell cycle progression in T-47D breast cancer cells is accompanied by induction of the cyclin-dependent kinase inhibitor p21.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590903056878

Progestins both stimulate and inhibit breast cancer cell cycle progression while increasing expression of transforming growth factor alpha, epidermal growth factor receptor, c-fos, and c-myc genes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590903056878

Hormonal regulation of the p53 tumor suppressor protein in T47D human breast carcinoma cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590903056878

Activation of the Src/p21ras/Erk pathway by progesterone receptor via cross-talk with estrogen receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590903056878

Non-transcriptional action of oestradiol and progestin triggers DNA synthesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590903056878

Two domains of the progesterone receptor interact with the estrogen receptor and are required for progesterone activation of the c-Src/Erk pathway in mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590903056878

ErbB2 promotes Src synthesis and stability: novel mechanisms of Src activation that confer breast cancer metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590903056878

Inhibition of protein kinase c-Src reduces the incidence of breast cancer metastases and increases survival in mice: implications for therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590903056878

Elevated Src activity promotes cellular invasion and motility in tamoxifen resistant breast cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590903056878

Src family kinases in tumor progression and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590903056878

Crosstalk between steroid receptors and the c-Src-receptor tyrosine kinase pathways: implications for cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590903056878

Progestin effects on breast cancer cell proliferation, proteases activation, and in vivo development of metastatic phenotype all depend on progesterone receptor capacity to activate cytoplasmic signaling pathways.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590903056878

Extra-nuclear signaling of progesterone receptor to breast cancer cell movement and invasion through the actin cytoskeleton

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590903056878

Effects of estradiol with micronized progesterone or medroxyprogesterone acetate on risk markers for breast cancer in postmenopausal monkeys.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590903056878

Differential effects of progestins on the circulating IGF-I system

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590903056878

Serum insulin-like growth factor-I and breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590903056878

Androgenic progestogens oppose the decrease of insulin-like growth factor I serum level induced by conjugated oestrogens in postmenopausal women. Preliminary report.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590903056878

Effects of HRT on serum levels of IGF-I in postmenopausal women.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590903056878

Positive effects on cardiovascular and breast metabolic markers of oral estradiol and dydrogesterone in comparison with transdermal estradiol and norethisterone acetate

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590903056878

Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: the Women's Health Initiative Randomized Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590903056878

Progestins in hormone replacement therapies reactivate cancer stem cells in women with preexisting breast cancers: a hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590903056878

Molecular portraits of human breast tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590903056878

Stem cells, cancer, and cancer stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590903056878

Prospective identification of tumorigenic breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590903056878

Progestins initiate a luminal to myoepithelial switch in estrogen-dependent human breast tumors without altering growth

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590903056878

Ovarian steroids and the human breast: regulation of stem cells and cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590903056878

Rare steroid receptor-negative basal-like tumorigenic cells in luminal subtype human breast cancer xenografts.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590903056878

Breast cancer and hormone-replacement therapy: the Million Women Study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590903056878

Circulating concentrations of insulin-like growth factor I and risk of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590903056878

10.3109/09513590903056878

21 January 2018

Identifiers

DOI

1 reference

21 August 2017

1 reference